Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Diagnostic criteria for apathy in neurocognitive disorders.

Tytuł:
Diagnostic criteria for apathy in neurocognitive disorders.
Autorzy:
Miller DS; Signant Health, Blue Bell, Pennsylvania, USA.
Robert P; Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.; Association Innovation Alzheimer, Nice, France.; Centre Memoire, Centre Hospitalier Universitaire de Nice, Nice, France.
Ereshefsky L; Follow the Molecule, Marina del Rey, California, USA.
Adler L; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Bateman D; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Cummings J; Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas, Nevada, USA.; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
DeKosky ST; Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Fischer CE; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; Keenan Research Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Husain M; Department of Experimental Psychology, University of Oxford, Oxford, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford, UK.
Ismail Z; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Jaeger J; CognitionMetrics, Wilmington, Delaware, USA.
Lerner AJ; University Hospitals - Case Western Reserve University, Cleveland, Ohio, USA.
Li A; Sunnybrook Research Institute, Toronto, Ontario, Canada.
Lyketsos CG; Johns Hopkins University, Baltimore, Maryland, USA.
Manera V; Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.; Association Innovation Alzheimer, Nice, France.
Mintzer J; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Moebius HJ; Moebius-Consult, Baar, Switzerland.
Mortby M; UNSW Ageing Futures Institute, The University of New South Wales, Sydney, Australia.
Meulien D; Clinical Research and Development, H. Lundbeck A/S, Valby, Denmark.
Pollentier S; Boehringer Ingelheim Pharma GmbH & Co KG, CNS Diseases Research, Biberach an der Riss, Germany.
Porsteinsson A; University of Rochester, Rochester, New York, USA.
Rasmussen J; Psi-Napse, Dorking, UK.
Rosenberg PB; Johns Hopkins University, Baltimore, Maryland, USA.
Ruthirakuhan MT; Sunnybrook Research Institute, Toronto, Ontario, Canada.
Sano M; Alzheimer Disease Research Center, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zucchero Sarracini C; Sunnybrook Research Institute, Toronto, Ontario, Canada.
Lanctôt KL; Sunnybrook Research Institute, Toronto, Ontario, Canada.; Departments of Psychiatry and Pharmacology/Toxicology, University of Toronto, Toronto, Ontario, Canada.
Źródło:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2021 Dec; Vol. 17 (12), pp. 1892-1904. Date of Electronic Publication: 2021 May 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Publication: 2020- : Hoboken, NJ : John Wiley & Sons, Ltd.
Original Publication: Orlando, FL : Elsevier, Inc.
MeSH Terms:
Consensus*
Delphi Technique*
Expert Testimony*
Apathy/*physiology
Neurocognitive Disorders/*classification
Neurocognitive Disorders/*diagnosis
Emotions ; Humans ; Motivation ; Neurocognitive Disorders/psychology
References:
Am J Geriatr Psychiatry. 2007 May;15(5):365-75. (PMID: 17463187)
Dement Geriatr Cogn Disord. 2006;22(4):352-7. (PMID: 16954691)
Jpn J Nurs Sci. 2017 Apr;14(2):135-145. (PMID: 27696678)
Psychiatry Res. 2013 Dec 30;210(3):1191-7. (PMID: 24094608)
J Am Geriatr Soc. 2017 Oct;65(10):2182-2189. (PMID: 28791690)
Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):213-9. (PMID: 21346517)
Neuropsychologia. 2018 Sep;118(Pt B):48-53. (PMID: 29410070)
J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1088-92. (PMID: 18187477)
Dement Geriatr Cogn Disord. 2012;33(2-3):204-9. (PMID: 22722671)
J Am Geriatr Soc. 2003 Apr;51(4):576-7. (PMID: 12657088)
PLoS One. 2015 May 14;10(5):e0126102. (PMID: 25974049)
Int J Geriatr Psychiatry. 2002 Dec;17(12):1099-105. (PMID: 12461757)
Cochrane Database Syst Rev. 2018 May 04;5:CD012197. (PMID: 29727467)
J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):134-9. (PMID: 1627973)
Alzheimers Dement. 2014 Nov;10(6):844-52. (PMID: 24798886)
Neuroimage. 2001 May;13(5):896-902. (PMID: 11304085)
J Alzheimers Dis. 2016 Nov 19;55(2):551-558. (PMID: 27802220)
Psychiatry Clin Neurosci. 2013 Nov;67(7):517-25. (PMID: 24147540)
Clin Rehabil. 2010 Dec;24(12):1102-11. (PMID: 20713437)
Am J Psychiatry. 2010 Jul;167(7):748-51. (PMID: 20595427)
Int Psychogeriatr. 2007 Feb;19(1):151-8. (PMID: 16870038)
J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):296-302. (PMID: 12154154)
Int Psychogeriatr. 2014 Feb;26(2):195-207. (PMID: 24135083)
Alzheimers Res Ther. 2018 Aug 18;10(1):83. (PMID: 30121084)
Int J Geriatr Psychiatry. 2010 Feb;25(2):133-41. (PMID: 19582757)
PLoS One. 2017 Jan 11;12(1):e0169938. (PMID: 28076387)
Int J Geriatr Psychiatry. 2013 Apr;28(4):383-92. (PMID: 22700526)
J Speech Lang Hear Res. 2004 Oct;47(5):1149-63. (PMID: 15603468)
Cereb Cortex. 2006 Jul;16(7):916-28. (PMID: 16207933)
Neurophysiol Clin. 2017 Feb;47(1):47-53. (PMID: 28161090)
Res Gerontol Nurs. 2009 Oct;2(4):267-75. (PMID: 20077983)
J Nerv Ment Dis. 2019 Sep;207(9):707-714. (PMID: 30256334)
J Affect Disord. 1993 Jun;28(2):117-24. (PMID: 8354767)
J Alzheimers Dis. 2018;66(3):1065-1082. (PMID: 30400094)
J Nerv Ment Dis. 1990 Jan;178(1):20-6. (PMID: 2136908)
Curr Gerontol Geriatr Res. 2012;2012:390701. (PMID: 22829814)
J Neuropsychiatry Clin Neurosci. 2014 Feb 25;26(4):134-141. (PMID: 24570144)
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1070-4. (PMID: 16024880)
Alzheimers Dement. 2021 Dec;17(12):1892-1904. (PMID: 33949763)
Int J Geriatr Psychiatry. 2017 Aug;32(8):922-930. (PMID: 27428560)
Am J Geriatr Psychiatry. 2020 Apr;28(4):410-420. (PMID: 31495772)
Dement Geriatr Cogn Disord. 2008;25(1):81-7. (PMID: 18042994)
Arch Gerontol Geriatr. 2009 Sep-Oct;49(2):246-249. (PMID: 19022508)
Schizophr Res. 2014 Aug;157(1-3):278-84. (PMID: 24875172)
Neurology. 2018 Mar 20;90(12):e1066-e1076. (PMID: 29453244)
Am J Geriatr Psychiatry. 2008 Jul;16(7):551-7. (PMID: 18591575)
J Neurol Neurosurg Psychiatry. 2006 May;77(5):579-84. (PMID: 16614016)
Schizophr Bull. 1987;13(2):261-76. (PMID: 3616518)
J Parkinsons Dis. 2012;2(2):161-6. (PMID: 23939440)
Neurosci Biobehav Rev. 2016 Oct;69:381-401. (PMID: 27527825)
Int J Geriatr Psychiatry. 2004 Sep;19(9):864-9. (PMID: 15352144)
J Affect Disord. 2016 Jan 15;190:264-271. (PMID: 26540080)
Dement Geriatr Cogn Disord. 2012;34(1):1-6. (PMID: 22854420)
Psychiatry Res. 1991 Aug;38(2):143-62. (PMID: 1754629)
Mov Disord. 2008 Nov 15;23(15):2129-70. (PMID: 19025984)
Eur Psychiatry. 2009 Mar;24(2):98-104. (PMID: 19201579)
J Alzheimers Dis. 2015;44(3):907-16. (PMID: 25374109)
Psychiatry Res. 2016 Aug 30;242:331-335. (PMID: 27336799)
Dement Geriatr Cogn Disord. 2012;34(2):96-111. (PMID: 22922821)
J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):130-49. (PMID: 18451185)
Curr Alzheimer Res. 2013 Jan;10(1):86-94. (PMID: 23016837)
J Neurol. 2014 Dec;261(12):2319-28. (PMID: 25228003)
Eur Psychiatry. 2018 Oct;54:71-76. (PMID: 30125783)
Stroke. 2009 Apr;40(4):1269-74. (PMID: 19228848)
Cortex. 2018 Jun;103:350-359. (PMID: 29704671)
Neurology. 1994 Dec;44(12):2308-14. (PMID: 7991117)
Int J Geriatr Psychiatry. 2018 Jan;33(1):141-150. (PMID: 28240379)
J Alzheimers Dis. 2017;56(3):929-938. (PMID: 28059789)
Neurologist. 2002 Jul;8(4):263-9. (PMID: 12803685)
J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):302-7. (PMID: 24247857)
J Am Geriatr Soc. 2005 Jan;53(1):24-33. (PMID: 15667372)
Int J Geriatr Psychiatry. 2009 Jul;24(7):680-5. (PMID: 19089875)
Neuropsychologia. 2018 Sep;118(Pt B):54-67. (PMID: 28689673)
Am J Alzheimers Dis Other Demen. 2016 Jun;31(4):341-50. (PMID: 26631687)
J Alzheimers Dis. 2013;33(2):535-43. (PMID: 23001707)
Int J Geriatr Psychiatry. 2012 Jul;27(7):722-6. (PMID: 22685067)
Am J Psychiatry. 1990 Jan;147(1):22-30. (PMID: 2403472)
Clin Neuropsychol. 2014;28(2):215-36. (PMID: 24502686)
Neurobiol Aging. 2012 Apr;33(4):791-803. (PMID: 20685009)
Mov Disord. 1994 Jan;9(1):76-83. (PMID: 8139608)
Int Psychogeriatr. 2013 Dec;25(12):1941-52. (PMID: 23992241)
Neurosci Biobehav Rev. 2019 Feb;97:10-33. (PMID: 30244163)
J Clin Psychopharmacol. 2008 Jun;28(3):296-301. (PMID: 18480686)
Am J Psychiatry. 2014 May;171(5):572-81. (PMID: 24700290)
Front Aging Neurosci. 2015 Sep 03;7:133. (PMID: 26388764)
Aging Clin Exp Res. 2012 Aug;24(4):305-16. (PMID: 22102508)
Neurosci Biobehav Rev. 2019 Feb;97:112-137. (PMID: 30312626)
Brain. 2015 Dec;138(Pt 12):3803-15. (PMID: 26490330)
Rev Recent Clin Trials. 2018;13(4):319-327. (PMID: 29658441)
Neurobiol Aging. 2013 Jul;34(7):1913-20. (PMID: 23414669)
Neuropsychiatr Dis Treat. 2016 Dec 23;13:61-67. (PMID: 28096673)
Dement Geriatr Cogn Disord. 2009;27(1):96-104. (PMID: 19158440)
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):8-11. (PMID: 16361584)
Annu Rev Clin Psychol. 2017 May 8;13:369-396. (PMID: 28482688)
Mov Disord. 2007 Nov 15;22(15):2156-61. (PMID: 17721877)
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1208-1214. (PMID: 29884723)
Eur Psychiatry. 2015 Feb;30(2):251-7. (PMID: 24630745)
Am J Psychiatry. 2018 Feb 1;175(2):99-100. (PMID: 29385833)
Int Psychogeriatr. 2018 Feb;30(2):177-184. (PMID: 28416030)
Am J Geriatr Psychiatry. 2012 Feb;20(2):142-8. (PMID: 22064613)
Alzheimers Dement. 2017 Jan;13(1):84-100. (PMID: 27362291)
Aging Ment Health. 2010 Nov;14(8):900-4. (PMID: 21069596)
Am J Geriatr Psychiatry. 2019 Aug;27(8):873-882. (PMID: 30910421)
J Neurol Sci. 2014 Dec 15;347(1-2):295-300. (PMID: 25455303)
J Am Med Dir Assoc. 2016 Aug 1;17(8):741-7. (PMID: 27184521)
Int Psychogeriatr. 2008 Jun;20(3):538-53. (PMID: 18289451)
BMC Geriatr. 2010 Jan 31;10:5. (PMID: 20113526)
Int J Geriatr Psychiatry. 2003 Nov;18(11):1037-42. (PMID: 14618556)
PLoS One. 2016 Aug 18;11(8):e0161092. (PMID: 27536962)
J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):314-9. (PMID: 9706539)
J Geriatr Psychiatry Neurol. 2017 Jan;30(1):26-49. (PMID: 28248559)
J Affect Disord. 2018 May;232:116-121. (PMID: 29481995)
Curr Opin Behav Sci. 2018 Aug;22:7-13. (PMID: 30123816)
Int J Geriatr Psychiatry. 2008 Apr;23(4):409-14. (PMID: 17918770)
Nat Rev Neurosci. 2018 Aug;19(8):470-484. (PMID: 29946157)
Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):62-7. (PMID: 22261729)
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):449-55. (PMID: 24133289)
Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):158-62. (PMID: 18525288)
Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):150-4. (PMID: 17545741)
Int Psychogeriatr. 2016 May;28(5):707-17. (PMID: 26572551)
J Clin Psychiatry. 2013 Aug;74(8):810-6. (PMID: 24021498)
J Alzheimers Dis. 2010;20(1):175-83. (PMID: 20164594)
Geriatr Gerontol Int. 2011 Oct;11(4):431-7. (PMID: 21518170)
Int J Geriatr Psychiatry. 2004 Nov;19(11):1087-94. (PMID: 15481065)
Int J Psychiatry Med. 2007;37(4):357-70. (PMID: 18441625)
Grant Information:
P30 AG066507 United States AG NIA NIH HHS; P20 AG068053 United States AG NIA NIH HHS; U01 NS093334 United States NS NINDS NIH HHS; P30 AG072980 United States AG NIA NIH HHS; P20 GM109025 United States GM NIGMS NIH HHS; R01 AG053798 United States AG NIA NIH HHS; K23 AG059914 United States AG NIA NIH HHS
Contributed Indexing:
Keywords: apathy; behavior; cognition; diagnostic criteria; emotion; motivation; neurocognitive disorder (NCD); neuropsychiatric symptoms (NPS)
Entry Date(s):
Date Created: 20210505 Date Completed: 20220210 Latest Revision: 20221016
Update Code:
20240104
PubMed Central ID:
PMC8835377
DOI:
10.1002/alz.12358
PMID:
33949763
Czasopismo naukowe
Introduction: Apathy is common in neurocognitive disorders (NCD) but NCD-specific diagnostic criteria are needed.
Methods: The International Society for CNS Clinical Trials Methodology Apathy Work Group convened an expert group and sought input from academia, health-care, industry, and regulatory bodies. A modified Delphi methodology was followed, and included an extensive literature review, two surveys, and two meetings at international conferences, culminating in a consensus meeting in 2019.
Results: The final criteria reached consensus with more than 80% agreement on all parts and included: limited to people with NCD; symptoms persistent or frequently recurrent over at least 4 weeks, a change from the patient's usual behavior, and including one of the following: diminished initiative, diminished interest, or diminished emotional expression/responsiveness; causing significant functional impairment and not exclusively explained by other etiologies.
Discussion: These criteria provide a framework for defining apathy as a unique clinical construct in NCD for diagnosis and further research.
(© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies